SCHEMBL6999639

SCHEMBL6999639

CC1Oc2ccc(/C=C/[N+](=O)[O-])cc2NC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.49
VCP P55072 5/20 0.48
NPC1 O15118 1/20 0.48
MTOR P42345 1/20 0.48
RAB9A P51151 1/20 0.48
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
FBP1 P09467 6/20 0.43
EGFR P00533 2/20 0.42
ABL1 P00519 1/20 0.42
ABL2 P42684 1/20 0.42
SMYD3 Q9H7B4 1/20 0.41
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GALR2 O43603 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
SYK P43405 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999641 1.00 PARP1 (0.49) PARP1VCPNPC1MTORRAB9A
SCHEMBL5188341 0.80 PARP1 (0.57) PARP1PDE3BPDE3ASMYD3ALDH1A1
SCHEMBL532347 0.80 PARP1 (0.57) PARP1PDE3BPDE3ASMYD3ALDH1A1
SCHEMBL5342897 0.80 PARP1 (0.57) PARP1PDE3BPDE3ASMYD3ALDH1A1
SCHEMBL7711338 0.79 PARP1 (0.52) PARP1PDE3BPDE3ASMYD3
SCHEMBL531954 0.79 ALOX5 (0.55) PARP1PDE3BPDE3ASMYD3ALDH1A1
SCHEMBL6998554 0.79 PARP1 (0.52) PARP1PDE3BPDE3ASMYD3
SCHEMBL531955 0.79 ALOX5 (0.55) PARP1PDE3BPDE3ASMYD3ALDH1A1
SCHEMBL6996421 0.78 PARP1 (0.48) PARP1PDE3BPDE3ASMYD3
SCHEMBL6996415 0.78 PARP1 (0.48) PARP1PDE3BPDE3ASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed